John Bramble: Ensuring Safe AI Integration in Medicine
John Bramble, Radiologist at Banner Health, shared a post on LinkedIn:
“There are customary steps in rolling out new treatment protocols.
Those protocols are reviewed by appropriate clinical committees (such as orthopedists reviewing venous thrombosis prevention protocols for patients undergoing joint replacement).
Documents are presented listing references to journal studies and professional society recommendations.
Discussions among physicians covering inclusion and exclusion criteria for application of the protocol needs to occur.
Just because you are using a large AI frontier model does not mean you should not complete the review of such protocols.
Oversight is mandatory.
If an AI model cannot provide the information necessary for oversight, it should not be used.
A real limitation of AI models is that they are not adequately trained on patients who are outliers, and outliers are far more common than most non clinicians think.
Ai applications in healthcare need significant oversight.
The amount of oversight needed may decrease in 5 -10 years after widespread use of an AI model, but there will always need to be some continuing oversight.
Both the healthcare organization and the AI model provider bear joint responsibility for oversight.”
Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments